Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-C Garcia-Pagan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Alimentary Pharmacology & Therapeutics|July 24, 2009
Does debugging the portal system decrease pressure?A De Gottardi, J-C Garcia-Pagan
Alimentary Pharmacology & Therapeutics|May 9, 2008
Review article: the modern management of portal hypertension--primary and secondary prophylaxis of variceal bleeding in cirrhotic patientsJ C Garcia-Pagan, A De Gottardi, J Bosch
Shock (Augusta, Ga.)|April 3, 1999
Patterns of vasoregulatory gene expression in the liver response to ischemia/reperfusion and endotoxemiaN V Sonin, J C Garcia-Pagan, K Nakanishi, et al.
Alimentary Pharmacology & Therapeutics|June 15, 2016
Editorial: measuring inflammatory and fibrotic components of portal hypertension - a non-invasive hepatic venous pressure gradient? Authors' replyT D Sandahl, H J Møller, S Møller, et al.
The American Review of Respiratory Disease|August 1, 1990
Effects of propranolol on arterial oxygenation and oxygen transport to tissues in patients with cirrhosisA G Agusti, J Roca, J Bosch, et al.
Gut|February 13, 2002
Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?A K Burroughs, R Groszmann, J Bosch, et al.
Gastroenterology|October 1, 1996
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressureJ Bruix, A Castells, J Bosch, et al.
Hepatology (Baltimore, Md.)|August 8, 1998
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systemsM Guevara, P Ginès, J C Bandi, et al.
Endoscopy|October 1, 1995
Duodenal variceal bleeding treated with a transjugular intrahepatic portosystemic shuntP Sort, I Elizalde, I Llach, et al.
Alimentary Pharmacology & Therapeutics|April 11, 2016
The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosisT D Sandahl, R McGrail, H J Møller, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Alimentary Pharmacology & Therapeutics|July 24, 2009
Does debugging the portal system decrease pressure?A De Gottardi, J-C Garcia-Pagan
Alimentary Pharmacology & Therapeutics|May 9, 2008
Review article: the modern management of portal hypertension--primary and secondary prophylaxis of variceal bleeding in cirrhotic patientsJ C Garcia-Pagan, A De Gottardi, J Bosch
Shock (Augusta, Ga.)|April 3, 1999
Patterns of vasoregulatory gene expression in the liver response to ischemia/reperfusion and endotoxemiaN V Sonin, J C Garcia-Pagan, K Nakanishi, et al.
Alimentary Pharmacology & Therapeutics|June 15, 2016
Editorial: measuring inflammatory and fibrotic components of portal hypertension - a non-invasive hepatic venous pressure gradient? Authors' replyT D Sandahl, H J Møller, S Møller, et al.
The American Review of Respiratory Disease|August 1, 1990
Effects of propranolol on arterial oxygenation and oxygen transport to tissues in patients with cirrhosisA G Agusti, J Roca, J Bosch, et al.
Gut|February 13, 2002
Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?A K Burroughs, R Groszmann, J Bosch, et al.
Gastroenterology|October 1, 1996
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressureJ Bruix, A Castells, J Bosch, et al.
Hepatology (Baltimore, Md.)|August 8, 1998
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systemsM Guevara, P Ginès, J C Bandi, et al.
Endoscopy|October 1, 1995
Duodenal variceal bleeding treated with a transjugular intrahepatic portosystemic shuntP Sort, I Elizalde, I Llach, et al.
Alimentary Pharmacology & Therapeutics|April 11, 2016
The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosisT D Sandahl, R McGrail, H J Møller, et al.
Pageof 2